Enriched in endometrial cancer; associated with gene regulation (PRSS33, CPB2, XBP1) involved in fibrin degradation and cell secretion; Increased abundance linked to inflammation and lung tissue changes, contributing to NSCLC progression. This evidence concerns the gene PRSS33 and non-small cell lung carcinoma.